Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Fizzotti

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Journal of Interferon Research|June 1, 1989
A phase I study of human natural interferon-beta in cancer patientsA M Liberati, B Biscottini, M Fizzotti, et al.
Leukemia|July 1, 1994
Simultaneous expression of RBTN-2 and BCR-ABL oncogenes in a T-ALL with a t(11;14)(p13;q11) and a late-appearing Philadelphia chromosomeM Fizzotti, E Y Chen, M P Link, et al.
The American Journal of Pathology|August 1, 1995
A specific monoclonal antibody (PG-B6) detects expression of the BCL-6 protein in germinal center B cellsL Flenghi, B H Ye, M Fizzotti, et al.
Journal of Interferon Research|December 1, 1988
Biochemical host response to interferon-betaA M Liberati, M Fizzotti, M G Proietti, et al.
Cancer|June 1, 1987
Immunologic profile in patients with Hodgkin's disease in complete remissionA M Liberati, E Ballatori, M Fizzotti, et al.
Cancer Research|April 15, 1995
ALL-1 gene rearrangements in acute myeloid leukemia: association with M4-M5 French-American-British classification subtypes and young ageG Cimino, M C Rapanotti, L Elia, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1988
A randomized trial to evaluate the immunorestorative properties of thymostimulin in patients with Hodgkin's disease in complete remissionA M Liberati, E Ballatori, M Fizzotti, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Biochemical and immunological responses of hairy cell leukemia patients to interferon betaA M Liberati, M Horisberger, M Schippa, et al.
Cancer Immunology, Immunotherapy : CII|May 1, 1994
Natural-killer-stimulatory effect of combined low-dose interleukin-2 and interferon beta in hairy-cell leukemia patientsA M Liberati, V De Angelis, M Fizzotti, et al.
Blood|March 9, 2000
A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cellsB Falini, M Fizzotti, A Pucciarini, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Journal of Interferon Research|June 1, 1989
A phase I study of human natural interferon-beta in cancer patientsA M Liberati, B Biscottini, M Fizzotti, et al.
Leukemia|July 1, 1994
Simultaneous expression of RBTN-2 and BCR-ABL oncogenes in a T-ALL with a t(11;14)(p13;q11) and a late-appearing Philadelphia chromosomeM Fizzotti, E Y Chen, M P Link, et al.
The American Journal of Pathology|August 1, 1995
A specific monoclonal antibody (PG-B6) detects expression of the BCL-6 protein in germinal center B cellsL Flenghi, B H Ye, M Fizzotti, et al.
Journal of Interferon Research|December 1, 1988
Biochemical host response to interferon-betaA M Liberati, M Fizzotti, M G Proietti, et al.
Cancer|June 1, 1987
Immunologic profile in patients with Hodgkin's disease in complete remissionA M Liberati, E Ballatori, M Fizzotti, et al.
Cancer Research|April 15, 1995
ALL-1 gene rearrangements in acute myeloid leukemia: association with M4-M5 French-American-British classification subtypes and young ageG Cimino, M C Rapanotti, L Elia, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1988
A randomized trial to evaluate the immunorestorative properties of thymostimulin in patients with Hodgkin's disease in complete remissionA M Liberati, E Ballatori, M Fizzotti, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Biochemical and immunological responses of hairy cell leukemia patients to interferon betaA M Liberati, M Horisberger, M Schippa, et al.
Cancer Immunology, Immunotherapy : CII|May 1, 1994
Natural-killer-stimulatory effect of combined low-dose interleukin-2 and interferon beta in hairy-cell leukemia patientsA M Liberati, V De Angelis, M Fizzotti, et al.
Blood|March 9, 2000
A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cellsB Falini, M Fizzotti, A Pucciarini, et al.
Pageof 4